Prasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, NDC: 51407-445-30.
Published September 9, 2026 · Recall initiated: August 21, 2026
Summary
FDA records drug Class II recall D-0847-2026, published September 9, 2026 and initiated August 21, 2026. Recalling firm: Golden State Medical Supply Inc.; Status: Ongoing; Reported quantity: 6791 30-count bottles; Lot: Lot # GS062298, Exp Date: 09/30/ 2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissolution
What to do
Voluntary: Firm initiated · Letter
Get an email if PRASUGREL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- PRASUGREL
- Manufacturer
- Golden State Medical Supply Inc.
- Distributor
- US Nationwide.
- Lot
- Lot # GS062298, Exp Date: 09/30/ 2026.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPrasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan PharmaceuticalsSeptember 9, 2026
- FDABuprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American HealthSeptember 9, 2026
- FDA0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 units per case. BaxterSeptember 9, 2026
- FDAPrasugrel Tablets, USP, 5 mg, 30-count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc.,March 26, 2025
- FDAPRASUGREL TABLETS, 5 mg, 30 tablet bottles, Rx only, packaged by GSMS, Incorporated, Camarillo, CA 93012 NDCMarch 26, 2025
- FDAPrasugrel Tablets 5 mg, 30-count bottles, Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WVNovember 6, 2019
Questions about this recall
Was Prasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, NDC: 51407-445-30. recalled?
Yes. FDA published recall D-0847-2026 on September 9, 2026. Reported hazard: Failed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissolution
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: PRASUGREL.